Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DCAF12 antisense RNA 1 (DCAF12-AS1)
- Target
- DCAF12-AS1
- Molecular classification
- Long noncoding RNA (lncRNA), Antisense RNA
01
Overview
DCAF12 antisense RNA 1 (DCAF12-AS1) is a human long noncoding RNA (lncRNA) gene expressed in an antisense orientation to the DCAF12 coding gene[2]. Like other lncRNA antisense transcripts, it likely regulates gene expression by interacting with the mRNA of adjacent genes or influencing chromatin states and transcriptional activity[4]. LncRNA antisense transcripts are increasingly recognized for their regulatory roles in processes such as X-chromosome inactivation, genomic imprinting, and cancer-related epigenetic silencing, although specific functional and disease associations for DCAF12-AS1 itself remain to be elucidated[4]. There is no evidence that DCAF12-AS1 acts as a therapeutic target, nor are there approved drugs that interact with it. If you require structured data for a protein target (e.g., DCAF12 itself, which is a substrate receptor for a cullin-RING ubiquitin ligase), please specify, as DCAF12-AS1 is a noncoding RNA transcript, not an actionable protein or therapeutic target[2][3][4].
- Other names
- DCAF12-AS1AL354989.1DCAF12 Antisense RNA 1
02
Biological functions
Regulation of gene expressionPotential involvement in epigenetic regulation and cancer pathways through antisense mechanisms
03
Disease associations
Other (general implication in gene regulation; specific disease associations not established in curated databases as of this search)
Beyond the preview
Go deeper on DCAF12 antisense RNA 1 (DCAF12-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DCAF12 antisense RNA 1 (DCAF12-AS1).